BurgosRCR, SchoemanJC, van WindenLJ, et al.Ultra-weak photon emission as a dynamic tool for monitoring oxidative stress metabolism. Sci Rep, 2017; 7:1229.
2.
HamblinMR.Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys, 2017; 4:337–361.
3.
HaldemanS, CarrollL, CassidyJD, SchubertJ, NygrenÅ. The bone and joint decade 2000–2010 task force on neck pain and its associated disorders. Eur Spine J, 2008; 17:5–7.
4.
JohnstoneD, MassriN, MoroC, et al.Indirect application of near infrared light induces neuroprotection in a mouse model of parkinsonism—an abscopal neuoroprotective effect. Neuroscience, 2014; 274:93–101.
5.
TrajanoLAdSN, da Silva SergioLP, StumboAC, MencalhaAL, FonsecaADS. Low power lasers on genomic stability. J Photochem Photobiol B, 2018; 180:186–197.
6.
LiebertA, BicknellB, AdamsR. Protein conformational modulation by photons: a mechanism for laser treatment effects. Med Hypotheses, 2014; 82:275–281.
7.
StojkovicK, WingSS, CermakianN. A central role for ubiquitination within a circadian clock protein modification code. Front Mol Neurosci, 2014; 7:69.
8.
LaaksoEL, CramondT, RichardsonC, GalliganJP. Plasma ACTH and β-endorphin levels in response to low level laser therapy (LLLT) for myofascial trigger points. Laser Ther, 1994; 6:133–141.
9.
NakahataY, BesshoY.The circadian NAD+ metabolism: impact on chromatin remodeling and aging. Biomed Res Int, 2016, Article ID 3208429, 7 pp.
10.
ZhangY, KornhauserJ, ZeeP, MayoK, TakahashiJ, TurekF. Effects of aging on light-induced phase-shifting of circadian behavioral rhythms, Fos expression and CREB phosphorylation in the hamster suprachiasmatic nucleus. Neuroscience, 1996; 70:951–961.
11.
BicknellB, LiebertA, JohnstoneD, KiatH. Photobiomodulation of the microbiome: implications for metabolic and inflammatory diseases. Lasers Med Sci, 2018:1–11.
12.
BlivetG, MeunierJ, RomanFJ, TouchonJ. Neuroprotective effect of a new photobiomodulation technique against Aβ25–35 peptide-induced toxicity in mice: novel hypothesis for therapeutic approach of Alzheimer's disease suggested. Alzheimers Dement (NY), 2018; 4:54–63.
13.
HsiaoWW, MetzC, SinghDP, RothJ. The microbes of the intestine: an introduction to their metabolic and signaling capabilities. Endocrinol Metab Clin North Am, 2008; 37:857–871.
14.
HartaiZ, KlivenyiP, JanakyT, PenkeB, DuxL, VecseiL. Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease. J Neurol Sci, 2005; 239:31–35.
15.
KennedyPJ, CryanJF, DinanTG, ClarkeG. Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology, 2017; 112:399–412.
16.
RanaG, DonizettiA, VirelliG, et al.Cortical spreading depression differentially affects lysine methylation of H3 histone at neuroprotective genes and retrotransposon sequences. Brain Res, 2012; 1467:113–119.
